CD70 and neoplasm: These HIT‐T cells exhibited greater antigen sensitivity and enhanced degranulation compared to conventional CAR‐T cells, thereby improving therapeutic efficacy for tumour cells with low CD70 expression and effective tumour growth suppression in preclinical models.93